Silo Pharma, Inc. Common Stock (SILO) is a publicly traded Healthcare sector company. As of July 7, 2026, SILO trades at $6.12 with a market cap of $6.97M and a P/E ratio of -12.52. SILO moved -0.64% today. Year to date, SILO is +18.48%; over the trailing twelve months it is -32.64%. Its 52-week range spans $3.32 to $50.55. Rallies surfaces SILO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Silo Pharma’s QwikAgents Joins NVIDIA Program to Enhance AI Agent Platform: Silo Pharma’s subsidiary QwikAgents joined the NVIDIA Developer Program to access AI software ecosystem resources, development frameworks and optimization tools for its autonomous enterprise AI agent platform. The platform, featuring persistent memory, multi-model routing, browser automation and secure data management, aims to accelerate enhancements and scalability for enterprise workflow automation.
| Metric | Value |
|---|---|
| Price | $6.12 |
| Market Cap | $6.97M |
| P/E Ratio | -12.52 |
| EPS | $-0.50 |
| Dividend Yield | 0.00% |
| 52-Week High | $50.55 |
| 52-Week Low | $3.32 |
| Volume | 170.83K |
| Avg Volume | 0 |
| Revenue (TTM) | $72.10K |
| Net Income | $-4.23M |
| Gross Margin | 38.57% |
SILO analyst coverage data. Average price target: $0.00.